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1. Introduction 
The fatigue that results from physical exercise is a multifactorial phenomenon that is 
comprised of complex interactions between physiological and psychological factors. Fatigue 
is assumed to be an inability to maintain the required force or power or an increasing 
difficulty to continue the work rate at a given exercise intensity. Taking into account that 
homeostasis disturbances may be harmful, fatigue should be considered a defense 
mechanism that prevents tissue damage by reducing the intensity of or even interrupting 
physical activity. 
Fatigue is known to have peripheral and/or central origins. Although most studies focus 
peripheral factors, which include circulatory, metabolic, muscular, nutritional and 
thermoregulatory disorders, exercise-induced cerebral metabolism and neurohumoral or 
neurotransmitter turnover are also implicated in fatigue genesis. “Central fatigue” refers to 
these central nervous system alterations that may prevent muscular and neural damage by 
failing to drive the muscles appropriately.  
Most authors consider central fatigue during prolonged exercise to be a consequence of the 
accumulation or depletion of neurotransmitters, serotonin in particular. Although the role of 
serotonergic neural trafficking on exercise performance has been well documented, 
dopamine and noradrenaline neurotransmissions also contribute to central fatigue. In 
addition to having their activity modified by exercise, all of these brain monoamines exhibit 
relevant thermoregulatory effects. These amines play an important role in the function of 
thermoregulatory centers, such as the preoptic area and the anterior hypothalamus, and it is 
hypothesized that changes in their turnover are associated with the development of fatigue 
as a consequence of heat imbalances. 
The brain is especially endangered by hyperthermia. For this reason, the exacerbation of 
exercise-induced hyperthermia appears to diminish the central nervous system drive to the 
working muscles; this protects the brain from thermal damage while causing a detriment to 
physical endurance. This effect is more pronounced when hyperthermia occurs 
simultaneously with inhibitory signals from the central nervous system, as in the case of 
altered neurotransmitter metabolisms. Even though it has been stated that central fatigue 
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coincides with critical high core body and brain temperatures, as well as increased heat 
storage, evidence indicates that complex and dynamic mechanisms are reliable regulators of 
exercise performance. In this way, the heat storage and the body heating rates associated 
with changes in neurotransmitter content in thermoregulatory centers emerge as important 
factors in determining fatigue. 
The main focus of this section is to link serotonin, dopamine and noradrenaline brain levels 
and exercise-induced hyperthermia with the onset of central fatigue. It is improbable that 
central fatigue is caused by a unique pathway; therefore the interaction between these 
systems may play an important role in establishing hyperthermia-induced central fatigue. 
From a health perspective, fatigue should be considered a warning sign that prevents the 
organism from the harmful consequences of sports activities.  
2. Fatigue as a defense mechanism during exercise 
Fatigue can disturb performance in many occupations, including firefighting, the military, 
construction and laboring, and it can limit participation in most recreational activities and 
sports (McKenna & Hargreaves, 2008). Understanding fatigue has implications far from 
those circumscribed to sports performance. In ill patients, fatigue and, thus, exercise 
limitations can drastically restrict daily activities and lead to a poor quality of life. Therefore, 
it is not surprising that exercise-induced fatigue has gained so much attention among 
researchers in the fields of exercise science and medicine.  
Exercise-induced fatigue has been traditionally defined as an elevation in the perception of 
effort to develop a desired force or power and also as an eventual inability to produce this 
force (Davis & Bailey, 1997; Enoka & Stuart, 1992). Many different models have been 
proposed in an attempt to understand the underlying mechanisms of fatigue. Since the early 
works by Fletcher and Hopkins (1907) and Hill et al. (1924), lactic acid production, 
cardiovascular system inefficiency, metabolic substrate depletion and waste product 
accumulation have been recognized as the main signs of fatigue. Until recently, most studies 
have dealt with exercise-induced fatigue under a failure perspective, which means that any 
limitation arising from exercising muscles would lead to an interruption in the motor task. 
In such an approach, the failure to maintain force depends on “peripheral” fatigue that 
occurs distal to the point of nerve stimulation and on “central” fatigue that results from a 
failure to voluntarily activate the muscle (Gandevia, 2001). However, it is important to 
emphasize that fatigue during exercise can occur without any signs of muscle dysfunction, 
substrate inadequacy within the exercised muscles or cardiovascular system overload; it 
may thus be under the influence of psychological factors such as arousal, mood and external 
motivation (Foley & Fleshner, 2008). 
A more recent approach differs from the failure perspective and points to a more integrative 
scenario where fatigue should be seen as a defense mechanism. Thus, exercise is ended or its 
intensity is turned down to protect the individual from tissue damage (Marino, 2004). In 
1996, Ulmer proposed the concept of teleoanticipation, where a feedback control system 
would exist for the optimal adjustment of the metabolic rate during exercise and would 
include a programmer that would take a finishing point into consideration. In this way, a 
marathon runner would consciously choose to run at a pace that would not pose a threat to 
himself. This assumption was further developed as the “Central Governor Model” that 
considers fatigue to be a sensation that results from a complex neural integration between 
afferent information and the brain (Noakes et al., 2005; Noakes & St Clair Gibson, 2004). 
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Peripheral information, such as substrate depletion and waste product accumulation, would 
act as a modulator of the cerebral control process in a dynamic, non-linear and integrated 
manner; this would cause an oscillatory behavior of the physiological responses and power 
output during exercise. This integrative model of fatigue proposes that a continuous 
interrelated control of feed-forward and feed-back mechanisms would exist and would be 
responsible for a secure system of homeostasis control during exercise (Noakes et al., 2005; 
Tucker, 2009; Tucker et al., 2006). This integration could be consciously and verbally 
manifested through the perception of effort, as measured by Borg’s scale (1982) (St Clair 
Gibson et al., 2006; Tucker, 2009). Moreover, the teleoanticipatory central nervous system 
would be molded by previous exercise experiences and training (Noakes et al., 2005). Thus, 
fatigue may provide the cognitive system with a signal that encourages the organism to 
lower present goals and/or seek lower effort alternative strategies (Perrey et al., 2010). 
In spite of being accepted by some research groups (Marino, 2010; Baron et al., 2009; Flouris 
& Cheung, 2009; Castle et al., 2006), this model has been criticized by others (Ament & 
Verkerke, 2009; Shephard, 2009).  As discussed later in this chapter, our group has been 
working with a conception of fatigue that goes in this direction. We have shown that before 
any harm can occur, afferent information from different physiological systems must be 
centrally integrated, and exercise must be voluntarily interrupted (Balthazar et al., 2009, 
Leite et al., 2010; A. G. Rodrigues et al., 2004, 2009; Soares et al., 2004, 2007). 
3. Central fatigue hypothesis  
Although most studies have focused on the peripheral factors of fatigue, including 
circulatory, metabolic, muscular, nutritional, and thermoregulatory disorders (Bassett & 
Howley, 2000; Coyle et al., 1986; Coyle & González-Alonso, 2001; Febbraio, 2000; 
Hargreaves & Febbraio, 1998; Kreider et al., 1993; Noakes, 2000), exercise-induced cerebral 
metabolism and neurohumoral or neurotransmitter alterations are also implicated in the 
genesis of fatigue (Foley & Fleshner, 2008; Nybo & Secher, 2004; Roelands & Meeusen, 2010). 
This participation of central nervous system factors in the reduction of the voluntary 
activation of skeletal muscles during physical effort has been termed “central fatigue” (Foley 
& Fleshner, 2008; Gandevia, 2001). In this section, a focused discussion on the possible role 
of serotonin neurotransmission on exercise-induced central fatigue will be presented.  
As first suggested by Newsholme et al. (1992), fatigue during prolonged exercise may be 
influenced by the activity of the brain serotonergic system; this has been commonly referred 
to as the ‘‘central fatigue hypothesis.’’ Its major premise is that elevated central tryptophan 
availability increases serotonin activity during prolonged exercise, which may cause fatigue 
by increasing lethargy and loss of central drive/motivation (Newsholme et al., 1992). 
During resting periods, most tryptophan, the amino acid precursor of serotonin, circulates 
in the blood bound to albumin, the same transporter of free fatty acids. During prolonged 
exercise and as a response to metabolic demands, there is an increase in the plasma 
concentration of free fatty acids. This displaces tryptophan from the biding sites on albumin 
and causes an elevation in the free portion of this amino acid. As a consequence, tryptophan 
is readily available to cross the blood-brain barrier. Concomitantly, during prolonged 
exercise, the plasma concentrations of branched-chain amino acids either fall or do not 
change. Because these amino acids and tryptophan in its free form share the same 
transporter across the blood-brain barrier, a reduction in plasma concentrations of 
branched-chain amino acids during exercise could increase the uptake of tryptophan into 
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the central nervous system and lead to an increase in serotonin synthesis during exercise. 
Thus, these two interrelated mechanisms underlie the “central fatigue hypothesis“. 
Tryptophan increases induced by exercise have been described as occurring simultaneously 
with a significant rise in the concentration of 5-hydroxyindoleacetic acid, which is the main 
serotonin metabolite; these data indicate that exercise increases serotonin synthesis and 
turnover. Tryptophan alters serotonin within the brain, and there is a positive relationship 
between endogenous serotonin content and the activity of tryptophan transport 
mechanisms in hypothalamic brain slices or synaptosomal preparations. Electrolytic lesions 
of raphe nuclei or intracerebroventricular injections of 5,7-dihydroxytryptamine lead to a 
decrease in synaptosomal tryptophan accumulation with reduced nerve terminals 
(Denizeau & Sourkes,1977). In addition, both spontaneous and electrically evoked serotonin 
release from hypothalamic slices have been shown to be dependent on precursor 
availability, which causes parallel changes in brain serotonin levels and serotonin release 
(Schaechter & Wurtman, 1990). 
Central serotonin activity can affect many physiological responses, such as pain tolerance 
(Prieto-Gomez et al., 1989), motor activity (Gerin & Privat, 1998), thermoregulation (Imeri et 
al., 2000; Lin et al., 1998; Myers, 1981, Soares et al., 2007) and hypothalamo–pituitary–
adrenal axis activity (Chaouloff, 2000; Korte et al., 1991). Thus, alterations in one or more of 
the physiological responses mediated by the serotonergic system may decrease work 
capacity during exercise. 
It has been shown that an increased availability of tryptophan, in the central nervous system 
reduces the mechanical efficiency and running time to fatigue, which are both related to 
serotonin content in the preoptic area (Soares et al., 2003, 2007). Moreover, serotonin content 
in the preoptic area is also associated with increased heat production and storage during 
exercise (Soares et al., 2007). Recently, it has been shown that alterations in the serotonin 
levels in the preoptic area and in the hypothalamus are also modulated by central 
angiotensinergic and cholinergic pathways (Leite et al., 2010; A. G. Rodrigues et al., 2009). 
For more details see section 7. 
Serotonergic neurons have many important functions in the central nervous system, 
including motor activity control. However, the role of serotonin in the regulation of motor 
control is complex. There is widespread evidence that serotonin in the hippocampus is 
involved in locomotion (Meeusen et al., 1996; Takahashi et al., 2000). According to Soares et 
al. (2007), at fatigue, the hippocampal serotonin content was directly correlated with the 
exercise time of rats but not correlated with the heat storage rate. Data from A. G. Rodrigues 
et al. (2009) also showed that, at fatigue, the hippocampal serotonin content was not directly 
correlated with heat storage. Together, these results suggest that hippocampal serotonergic 
activity might also participate in fatigue during exercise through a mechanism other than 
thermoregulation. This is in agreement with reports that serotonergic neurons in the median 
raphe nuclei that project to the hippocampus are related to motor activity (Hillegaart & 
Hjorth, 1989; Jacobs et al., 1975). 
Although the involvement of serotonin in central fatigue has been well documented, it has 
become evident that other neurotransmitters participate in the mechanisms of exercise-
induced fatigue (Lacerda et al., 2006; A. G. Rodrigues et al., 2009). These data indicate that 
central fatigue is a more complex phenomenon than previously thought and that it involves 
the balance of at least two central aminergic neurotransmitter systems, as indicated by the 
serotonin/dopamine ratio (Balthazar et al., 2010; Foley & Fleshner 2008; Meeusen, 2006).  
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4. Proposed central mechanisms of fatigue 
Fatigue should be seen as a multifaceted phenomenon influenced by both central and 
peripheral factors (Meeusen et al., 2006; Nybo & Secher, 2004). There is no doubt that 
alterations within the muscle contribute to exercise-induced fatigue; however, it is unlikely 
that alterations in muscle function are the sole mechanism of fatigue. In fact, the 
contribution of either central factors or factors upstream of the neuromuscular junction has 
been, for the most part, ignored in the literature (Foley & Fleshner, 2008). 
At least three factors have been proposed to contribute to the delay in establishing the role 
of “central” factors in human muscle fatigue. First, it has simply been more convenient to 
assume that the muscle limits to produce force that have been established in reduced 
preparations of muscle that are devoid of effective neural input also apply to a conscious 
human subject. Second, the existing methods to gauge the central drive to muscles have not 
always been technically rigorous, and findings obtained with these methods have been 
easily criticized or ignored. Third, although changes in the central nervous system during 
exercise can be measured, it has been more demanding to show that they cause a deficit in 
force production (Gandevia, 2001). 
Because muscle contractions are under the control of the central nervous system, it is likely 
that any significant alteration in the brain or the spinal cord would alter the neural drive to 
the neuromuscular junction, thus initiating fatigue (Taylor & Gandevia, 2008). In order to 
identify the adjustments that occur within the nervous system during fatiguing contractions, 
most studies have investigated the influence of afferent feedback, descending inputs, and 
spinal circuitry on the output of the motor neuron pool (Hunter et al., 2004). For example, 
the metabolites that accumulate in muscles during a prolonged exercise excite afferent 
fibers; these fibers enhance the central drive to maintain muscle perfusion by increasing the 
mean arterial pressure and modulating the motor neuron discharge rate (Gandevia, 2001). 
Such observations indicate that the decrement in force during a fatiguing contraction 
usually involves multiple neural mechanisms (Hunter et al., 2004). 
During maximal voluntary isometric tasks, voluntary activation usually diminishes, and 
motor unit firing rates decline (Gandevia, 2001). However, it is not possible to clearly specify 
all of the putative sites within the central nervous system at which contributions to voluntary 
activation, central fatigue, and supraspinal fatigue occur. The traditional model indicates that 
there is a “chain”, from higher levels within the central nervous system to the motoneuron via 
descending paths, and then through motor axons to the neuromuscular junction, the 
sarcolemma, T tubules, and, ultimately, to actin and myosin (Taylor & Gandevia, 2008). 
Thus, central fatigue can be considered to be an impaired muscular performance that arises 
from decreased efferent signaling from the central nervous system.  There are two general 
ways to study central fatigue. The first one seems to be a fairly direct way, and consists of 
using a technique where “added force” is determined. This occurs by overlaying a 
supramaximal electrical stimulus of a muscle onto a maximal voluntary contraction for that 
muscle. Any “added force” that may be generated that is in addition to that produced by the 
maximal voluntary contraction is indicative of an impairment from the central nervous 
system down to the level proximal to the neuromuscular junction. The second way to study 
central fatigue is to use an exogenous substance that is believed to induce central fatigue, 
and observe its effects on exercise capacity. However, unlike the first alternative, this 
method is indirect, because it cannot be exactly known if the substance had peripheral 
and/or central effects (Evans & Lambert, 2007).  
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4.1 Central nervous system biochemical changes and central fatigue 
Given that intense exercise challenges the cardiovascular, respiratory, endocrine, and 
peripheral and central motor systems, changes in many central nervous system transmitter 
systems would be expected to accompany exercise and task failure or fatigue (Gandevia, 2001). 
All types of physical or psychological constraints lead to the activation of noradrenergic, 
dopaminergic and serotonergic systems at the brainstem level. These systems are 
particularly important for the global regulation of behavior, and they participate in the 
formulation of an adapted response of the central nervous system to an external stimulus 
(Sesboue & Guincestre, 2006).  
The widespread central actions of many of these systems make it unlikely that any one is 
uniquely responsible for central fatigue. For example, there are serotonergic projections 
from the brain stem raphe nuclei to the cortex, hippocampus, hypothalamus, medulla, and 
spinal cord. There are noradrenergic projections from the locus coeruleus. Arousal, 
motivation, attention, tolerance to discomfort, and sensitivity to stress can all alter voluntary 
drive, at least subjectively, which suggests that many neural systems can modify central 
fatigue (Gandevia, 2001). 
There is evidence of the roles of these neuromodulators on fatigue that will be minutely 
covered later in this chapter. However, it is important to first elucidate some aspects of the 
interrelatedness of central neuromodulators and fatigue. We have already discussed some 
aspects of serotonergic neurotransmission and its implication on the central fatigue during 
exercise. 
Central noradrenergic neurons modulate humor and motivation, and when their activity is 
low, motivation decreases. This decrease leads to a diminishment of motor cortex activation 
and a subsequent decline in the stimulation of the descending path chain to the 
motoneurons (Sesboue & Guincestre, 2006).  On the other hand, the response of cerebral 
dopamine to, for example, a physical constraint is biphasic. It has been shown that there is a 
small elevation in the levels of this neurotransmitter at the beginning of muscle work, which 
is followed by a reduction in its concentration as the intensity and duration of the effort 
increases; this reduction is most prominent at fatigue (Foley & Fleshner, 2008).  
There are several other transmitters and their subtypes that need to be examined for their 
role in central fatigue. For example, it is already known that brain gamma-aminobutyric-
acid (GABA) levels diminish with exercise (Gandevia, 2001) and that baclofen, a GABAergic 
agonist that acts on GABA B receptors, can postpone fatigue (Abdelmalki et al., 1997). Other 
humoral signals that must be considered to be involved in central fatigue are glutamine and 
ammonia, which are diminished and increased, respectively, after exercise (Gandevia, 2001).  
Another important proposed mechanism of central fatigue is related to hyperthermia during 
exercise. It is well known that hyperthermia reduces the central nervous system drive for 
exercise performance (Nielsen et al., 1993; Walters et al., 2000) and precipitates feelings of 
fatigue during exercise. However, this essential aspect of central fatigue will be discussed in 
detail in the next section. 
5. Fatigue induced by exercise hyperthermia 
It has been shown that hyperthermia reduces physical performance in many mammalian 
species (Bruck & Olschewski, 1987; Fuller et al., 1998; González-Alonso et al., 1999; Nielsen 
et al., 1993; Walters et al., 2000), reduces central nervous system drive for exercise 
performance (Nielsen et al., 1993; Walters et al., 2000) and precipitates feelings of fatigue at a 
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sublethal threshold by establishing a safety level against heat stroke, thus protecting the 
brain, among other tissues, from thermal damage (Caputa et al., 1986; Marino,2004). The 
reduction in exercise performance as a consequence of hyperthermic stress has been 
described in isometric tasks (Nybo & Nielsen, 2001; Thomas et al., 2006; Todd et al., 2005), in 
dynamic exercises with fixed intensity, i.e., a constant workload (Nybo & Nielsen, 2001), and 
in self-paced prolonged exercises (Ely et al., 2010; Tatterson, 2000). Recently, from an 
evolutionary perspective, it has been suggested that physiological and (or) psychological 
safeguards should protect individuals by voluntarily reducing exercise and metabolic heat 
production before catastrophic hyperthermia (Cheung, 2007).  In fact, various animals will 
cease exercise when their core temperatures exceed safe limits, and there must be a similar 
behavioral response in humans to reduce metabolic heat production and ultimately to 
protect the physiological integrity (Cheung & Sleivert, 2004). 
5.1 Body temperature and thermoregulation 
Humans possess efficient physiological and behavioral mechanisms for maintaining their 
internal temperature within narrow limits; these mechanisms allow survival even in 
diversified thermal environments such as tropical forests, deserts and very cold regions. Our 
body temperatures are carefully regulated at 37°C ± 1°C. However, our thermal physiology 
is “asymmetrical”, which means that body temperature is placed very closely, within just a 
few degrees Celsius, to the upper existence limit (possibly related to the denaturation of 
regulatory proteins) but somewhat far, a few tens of degrees, from the lower survival limit 
(probably defined by the freezing temperature of water) (Romanovsky,2007). 
The lowest values for body temperature occur in the morning, between 04:00 and 06:00 a.m., 
and the highest are observed between 17:00 and 20:00 h (Waterhouse et al., 2005). It should be 
noted that the temperature is not the same throughout the human body. There is a 
temperature gradient between the core (visceral) and body surface (cutaneous). With an 
elevation in body temperature to values over 42°C, there is an eminent risk of protein 
denaturating with subsequent cellular death. However, despite being more tolerant to 
hypothermia than to hyperthermia (see above) when the former is severe, i.e., when body 
temperature falls below 32°C, there are critical risks for life maintenance that include the loss 
of motor coordination, cardiac arrhythmias and even death by cardiac arrest (Kanosue, 2010). 
Body temperature is the net result of the heat produced by metabolic actions and the heat 
dissipated to the environment. If the heat dissipation is smaller than heat production, 
excessive heat is stored and body temperature increases. 
Metabolism generates heat from exergonic oxidative reactions that use adenosine 
triphosphate (ATP) as fuel. Basal metabolism is around 50% efficient, and the remaining 
energy is lost as heat. Exercising muscles are even less efficient, at no more than 25%. For 
example, given that the mean value for the specific heat of body tissue is 0.83 kcal.kg-1.º C-1, 
a male adult weighting 70 kg with a body temperature of 37°C has around 2,150 Kcal of total 
heat stored in his body. 
The basal metabolism produces 1 Kcal. kg-1.h-1, even in a thermoneutral environment, where 
temperature regulation is achieved only by means of sensible heat loss, i.e., without regulatory 
changes in metabolic heat production or evaporative heat loss. Because human tissues only 
need 0.83 kcal.kg-1 to increase the internal (core) temperature by 1°C, core temperatures would 
be elevated by 1°C.h-1, even during rest periods, if no heat loss mechanisms are activated. 
Thus, losing heat to the environment is essential for survival. If there were no effective means 
by which body could lose heat, hyperthermia would be achieved very rapidly. 
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Thermoregulation is a typical example of an integrative hypothalamic function that 
generates autonomic, endocrine, motor and behavioral patterns as a response to an external 
challenge. Thermoregulation systems are composed of multiple independent neural 
pathways that have both feedback and feedforward mechanisms; these mechanism are 
activated by afferent information from peripheral temperature sensors and modulate the 
relationship between ambient and skin temperatures (Mekjavic & Eiken, 2006; Webb, 1995). 
The endothermic/homoeothermic animals are relatively independent from environmental 
conditions because they are able to regulate their body temperature through an association 
of autonomic and behavioral mechanisms (Mekjavic & Eiken, 2006; Schlader et al., 2009, 
2010). The autonomic processes consist of involuntary thermoeffector responses, either to 
heat or cold, which modify heat production and dissipation rates, and include sweating, 
shivering and vasomotor alterations at the body surface (IUPS, 2001). However, as pointed 
out by some authors (Schalader et al, 2010; Romanovsky, 2007), those autonomic responses 
have a limited capacity to regulate body temperature. In contrast, behavioral mechanisms of 
thermoregulation are intended to establish a thermal environment that represents a 
preferred condition for heat exchange (heat gain, heat loss, or heat balance) between the 
organism and its environment. The responses involved in such regulation include moves to 
a different thermal ambiance, changes in posture, wetting of body surfaces, changes in 
microclimate by nest building, parental behavior (huddling), and, in humans, voluntary 
exercise and cultural achievements (e.g. clothing, housing, and air-conditioning) (IUPS, 
2001).The association of behavioral and autonomic responses allows humans to survive in 
different and extreme environments (Mekjavi & Eiken, 2006). 
Vasomotion and evaporation are the main mechanisms of heat defense. However, sweating 
(or panting) usually starts at a higher threshold temperature than skin vasodilation. Thus, 
sweating functions as a second line of defense for situations where an increase in skin blood 
flow alone is not sufficient to prevent a serious increase in body temperature.  Cold defense 
processes operate in a parallel manner such that non-shivering thermogenesis is activated 
before shivering (Kanosue et al., 2010). 
5.2 Exercise hyperthermia and fatigue 
Because the mechanical efficiency of active muscles is around 25%, most of the remaining 
energy produced during exercise should be dissipated to the environment; otherwise, 
exercise may impose thermal stress to the organism. This dissipation can be hard if exercise 
takes place in a warm environment where heat dissipation mechanisms, such as conduction 
and radiation, are impaired. Dissipation can be even worse if it is associated with high 
humidity because heat lost by sweat evaporation would be severely compromised.  In these 
environmental conditions, keeping up the same intensity effort during physical exercise 
could lead to a harmful situation in which the heat dissipation would be insufficient to 
compensate for the heat production. As a result, the body temperature would continuously 
increase, and a thermal equilibrium would not be reached. 
To avoid serious injuries induced by excessive body heat storage and subsequent 
hyperthermia, it is imperative that the related activation of both the autonomic and 
behavioral responses, along with the different physiological systems, results in a decrease of 
exercise intensity or even in a termination of the activity (Cheung, 2007). 
An elevation in internal body temperature and an increase in heat storage have been 
proposed as limiting factors to physical performance. Recent data support the hypothesis 
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that both the heat storage rate and the internal body temperature seem to be the important 
determinants of fatigue during exercise (Balthazar et al., 2010; Coelho et al., 2010; Garcia et 
al., 2006; Lacerda et al., 2005; Leite et al., 2006; Magalhães et al., 2010; Nassif et al., 2008; A. 
G. Rodrigues et al., 2008; Soares et al., 2004, 2007). Thus, dissipation of heat from the body is 
thought to be more important than the control of heat production in the regulation of body 
temperature during exercise (Cheung & Sleivert, 2004).  
Temperature regulation during exercise can be divided into two phases. During the first 
minutes of exercise, in what has been called the dynamic phase, there is a imbalance 
between heat production, which depends mainly on exercise intensity, and heat dissipation; 
this imbalance results in an abrupt increase in body (internal) temperature. Rapid peripheral 
vasoconstriction, mediated by the noradrenergic sympathetic system and observed at this 
earlier phase, impairs heat dissipation during this stage of exercise and leads to 
hyperthermia. Venous blood that drains exercising muscles brings excessive heat to the 
body core. Hypothalamic thermosensors detect the increase in blood temperature, and the 
thermal integrative center of the hypothalamus activates efferent heat loss mechanisms. The 
second phase of exercise, known as the steady phase of thermal balance, begins as thermal 
thresholds for heat dissipation mechanisms (vasodilation and sweating) are attained 
(Lacerda et al., 2006). From this point on, there is an increase in skin blood flow, mediated 
by the vasodilator cholinergic sympathetic system, which parallels the increase in the 
sweating rate. These autonomic actions increase the body heat dissipation and minimize the 
body temperature elevation. When heat storage reaches a critical limit, protective fatigue 
occurs independently of body energy stores. This excessive stored heat reduces the 
motivation for voluntary exercise before the individual integrity is compromised.  
Neuromuscular control and hyperthermia have been widely investigated, and it has been 
consistently shown that hyperthermia diminishes neuromuscular activation (Morrison et al., 
2004; Nybo & Nielsen, 2001; Todd et al., 2005). A model has been proposed that suggests that 
this impairment causes systemic failures in order to protect the organism from severe heat 
injuries (Cheung, 2007). A reduction in the central drive to the motor neuron pool during 
hyperthermia is thought to result from at least two possibilities. One considers that there is a 
reduction in the descending message from the higher brain impulses to the motor neurons. 
The other indicates that inhibition occurs subcortically, at the site of the motor neurons, where 
afferent feedback may decrease the excitability of those motor neurons (Cheung & Sleivert, 
2004). The reduction in central drive may also result from both of these possibilities. 
Brain function may also be altered during hyperthermia. Changes in behavior seen with 
overheating, such as confusion, a loss of coordination, syncope, and, in extreme hyperthermia, 
a loss of consciousness or seizures, have been consistently observed (Fuller et al., 1998; 
Schlader et al., 2010; Walters et al., 2000). These data indirectly suggest a change in central 
nervous system function with hyperthermia (Cheung & Sleivert, 2004; Nybo, 2008). Brain 
activity, specifically the ratio of low frequency (┙: 8 –13 Hz) and high frequency (┚: 13–30 Hz) 
brainwaves, is an indicator of arousal during hyperthermia. Exercise has been investigated in 
subjects cycling at 60% aerobic power in both a hot ( 40°C) and cool (19°C) environment 
(Nielsen et al., 2001). There was a reduction in ┚ waves in the hot exercise condition such that 
the ratio of ┙ to ┚ waves increased, which indicates a reduced state of arousal in hyperthermic 
subjects. Moreover, the magnitude of the increase in the ┙ to ┚ wave ratio was correlated to 
elevated core temperatures. In the same study, subjects continually rated their perception of 
effort to be higher during hyperthermic condition (Nielsen et al., 2001).  
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Another important aspect regarding fatigue induced by exercise hyperthermia is 
cardiovascular function. It has been suggested that cardiovascular strain accompanying 
hyperthermia could indeed be one of the main factors underlying fatigue (Cheung & 
Sleivert, 2004). When heat production during exercise surpasses the capacity for heat 
dissipation to the environment and hyperthermia consequently develops, the ability to 
maintain cardiac output is jeopardized because stroke volume declines as the core 
temperature increases (Nybo, 2008). The competition between metabolic and 
thermoregulatory demands for blood flow during exercise may also accelerate the onset of 
fatigue through localized ischemia in specific tissues such as the brain or the gastrointestinal 
tract. Reduced blood flow to the gastrointestinal tract during exercise in heat may 
compromise the integrity of the intestinal walls (Sakurada & Hales 1998). As a result, the 
eventual leakage of lipopolysaccharides (endotoxins) into the circulation, a well-
documented response to severe exercise-induced hyperthermia, can occur. It is important to 
point out that an occurrence of endotoxemia can trigger a cascade of detrimental 
physiological responses mediated by cytokines, which can induce a fever-like situation and 
can accelerate heat storage and heat stroke.  
Neurohumoral factors, primarily disturbances in cerebral neurotransmitter levels, are part 
of the diverse mechanisms underlying fatigue induced by exercise hyperthermia. It is clear 
that several neurotransmitter systems are activated during exercise and that several of these 
systems affect the preoptic area and the anterior hypothalamus, which is of major 
importance for thermoregulation (Nybo, 2008). Therefore, it is important to highlight studies 
that correlate high heat storage and heating rates with elevated levels of serotonin in centers 
essential for thermoregulation (Leite et al., 2010; A. G. Rodrigues et al., 2009; Soares et al., 
2007). However, there are only a few that have examined whether hyperthermia alters 
monoamines and other neurotransmitter levels in the brain during exercise.  Although this 
subject will be discussed in detail in subsequent topics in this chapter, it is essential to first 
call attention to some aspects.  
Among the monoamines, serotonin is of particular interest because it influences arousal 
levels. If serotonin levels increase, this could contribute to an increase in perceived effort 
and a reduction in work rate, actions that have often been observed during hyperthermia 
(Cheung & Sleivert, 2004).  In contrast, because dopamine and noradrenaline have been 
associated with arousal, motivation, reinforcement and reward, control of motor behavior 
and mechanisms of addiction, some authors have investigated the role of these 
neurotransmitters on fatigue induced by exercise hyperthermia (Meeusen et al., 2006). 
Recently, it has been demonstrated that an alteration in dopamine transmission induced by 
the central blockade of dopamine D1 and D2 receptors impaired running performance in 
rats by decreasing the tolerance to heat storage. Furthermore, this blockade also impaired 
both the dissipation of exercise-induced heat and the recovery of the metabolic rate during 
the post-exercise period. These data provide evidence that the central activation of either 
dopamine D1 or D2 receptors may be essential for heat balance and exercise performance 
(Balthazar et al., 2010). 
6. Ergogenic and ergolytic amines 
Most theories consider central fatigue during prolonged exercise to be a consequence of 
changes in neurotransmitter turnover, particularly in the serotonergic system (Foley & 
Fleshner, 2008; Hasegawa et al., 2008; Nybo & Secher, 2004; Roelands & Meeusen, 2010). 
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Although the role of serotonergic neural traffic on exercise performance has been well-
documented, evidence demonstrates that dopaminergic and noradrenergic 
neurotransmissions contribute to central fatigue as well (Foley & Fleshner, 2008; Hasegawa 
et al., 2008; Nybo & Secher, 2004; Roelands & Meeusen, 2010). Interestingly, all of these brain 
monoamines, in addition to having their activity modified by exercise, exhibit relevant 
thermoregulatory effects (Balthazar et al., 2009; Foley & Fleshner, 2008; Hasegawa et al., 
2008; Roelands & Meeusen, 2010; Soares et al., 2004, 2007). It has been proposed that shifts in 
the turnover of these amines, which play an important role in the centers responsible for 
body temperature control, like the preoptic area and the anterior hypothalamus, may be 
associated with the development of fatigue coupled with heat imbalance.  
6.1 Serotonin  
Many authors have provided convincing evidence of the involvement of serotonin on the 
development of central fatigue (Blomstrand et al., 1989; Chaouloff, 1997; Fernstrom & 
Fernstrom, 2006; Gomez-Merino et al., 2001, Soares et al., 2007). The major premise is that 
increased brain serotonergic activity contributes to the onset of fatigue, possibly through its 
influence on many behavioral functions, such as elevated feelings of lethargy, tiredness and 
a loss of drive (Blomstrand, 2006; Meeusen et al., 2006; Roelands & Meeusen, 2010; Soares et 
al 2004, 2007). In contrast, low serotonin brain levels would favor improved exercise 
performance through the maintenance of motivation and arousal.  
One the first studies that associated physical activity with elevated levels of serotonin in the 
central nervous system is Barchas & Freedman (1963), who reported high brain serotonin 
activity in rats who swam until exhaustion. Since then, many findings have confirmed that 
serotonin levels in the central nervous system increase during exercise and peak at the 
fatigue point (Blomstrand et al., 1989; Chaouloff, 1997; Fernstrom & Fernstrom, 2006; 
Gomez-Merino et al., 2001, Soares et al., 2007). Exercising until fatigue has been shown to 
cause an increase in the levels of both serotonin and its metabolite 5-hydroxyindoleacetic 
acid (5-HIAA) in the brain stem and hypothalamus and an additional increase in the level of 
5-HIAA in the hippocampus and striatum. The authors concluded that because there was an 
increase in the turnover of serotonin in some parts of the brain, these may play a role in 
physical performance (Blomstrand et al., 1989). Gomez-Merino et al. (2001) examined the 
impact of acute intensive treadmill running on serotonin levels in the hippocampus and the 
frontal cortex and observed high levels of the monoamine in both regions after 90 minutes of 
exercise. In these same regions, as well as in the hippocampus, Soares et al. (2007) and A. G. 
Rodrigues et al. (2009) reported elevated concentrations of serotonin after running until 
fatigue. More recently, Caperuto et al. (2009) reported that although swimming training 
induced similar hypothalamic serotonin concentrations as sedentarism, its concentration in 
this brain region increased after an exhaustive training program with an insufficient 
recovery period. The data led to the hypothesis that elevated serotonin content may 
contribute to poor exercise performance during periods of excessive training.  
A special focus has been given to the pharmacological manipulations used to elucidate the 
relationship between increased serotonergic activity and the early onset of fatigue (Bailey et 
al., 1993; Roelands et al., 2009). A study by Bailey et al. (1993) demonstrated that exercise 
performance benefitted from the use of a serotonin antagonist, while treatment with a 
serotonin agonist led to a detriment in exercise performance. Similarly, increased brain 
serotonin availability during exercise results in poor physical performance (Soares et al., 
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2004, 2007). Reduced exercise performance related to higher serotonin content in the 
preoptic area and the hypothalamus was also verified after a central blockade of 
angiotensinergic synapses (Leite et al., 2010). Serotonin reuptake inhibitors have also been 
widely used, with the purpose of investigating the relationship between the 
neurotransmitter and central fatigue (Meeusen et al., 2001; Pannier et al., 1995; Parise et al., 
2001; Struder et al., 1998; W. M. Wilson et al., 1992). However, the results are contradictory 
and inconclusive. Although data have demonstrated no effect of different serotonin 
reuptake inhibitors (pizotifen, fluoxetine, citalopam) on exercise performance in humans 
(Meeusen et al., 2001; Pannier et al., 1995; Parise et al., 2001; Roelands et al., 2009; Strachan et 
al., 2004), findings from Struder et al. (1998) and W. M. Wilson et al. (1992) indicate that 
fatigue occurs sooner with pharmacological augmentation of the brain’s serotonergic 
activity by serotonin re-uptake inhibitor (paroxetine) supplements. These different outcomes 
might be explained by divergent exercise protocols, pharmacological manipulations, drug 
receptor specificity and drug dosages.  
Recent evidence indicates that serotonin neurotransmission also contributes to the 
development of central fatigue through its interference with thermoregulation. Particularly 
in the preoptic area/anterior hypothalamus, increased serotonin availability has been 
associated with hyperthermia that was brought about by an increase in metabolic heat 
production and a decrease in heat loss (Lin et al., 1998; Soares et al., 2004, 2007).The central 
treatment with tryptophan during exercise results in the precipitation of fatigue due to a 
disruption of the thermal balance, which accelerates the increase in exercise-induced 
hyperthermia (Soares et al., 2004, 2007). This finding indicates an important role of serotonin 
in thermoregulation during exercise and agrees with the observation that the rate of body 
heating reduces the central nervous system drive for exercise performance (Soares et al., 
2004, 2007). In fact, the data show that tryptophan-induced central fatigue due to 
hyperthermia and increased heat storage was intimately related to enhanced serotonin 
content in the preoptic area. In other words, increased serotonergic tonus in the preoptic 
area contributed to the aggravation of hyperthermia during exercise and the earlier 
settlement of central fatigue (Soares et al., 2007). This assumption is also true after the 
central manipulation of angiotensinergic transmissions (Leite et al., 2010). The central 
fatigue due to intense hyperthermia that was induced by central angiotensinergic inhibition 
was related to higher serotonin content in the preoptic area and the hypothalamus. In 
contrast, central cholinergic stimulation was associated with a decreased elevation in body 
temperature during exercise by abolishing the exercise-induced increase in serotonin 
content in the preoptic area (A. G. Rodrigues et al., 2009). These data emphasize that the 
onset of hyperthermic central fatigue seems to depend greatly on serotonin trafficking in 
thermoregulatory centers. 
6.2 Dopamine 
Although the role of serotonin in central fatigue has been well-documented, there is data 
that shows that dopamine also influences central fatigue (Balthazar et al., 2009, 2010; Foley 
& Fleshner, 2008; Hasegawa et al., 2008). Dopamine neurotransmission is associated with 
many physiological functions that could modify running performance, such as arousal, 
motivation, reinforcement, reward, motor behavior control and mechanisms of addiction 
(Balthazar et al., 2009, 2010; Foley & Fleshner, 2008; Hasegawa et al., 2008; Meeusen et al., 
2007).  
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Central dopamine metabolism has been shown to increase in several brain regions during 
exercise (Balthazar et al., 2009; Foley & Fleshner, 2008; Hasegawa et al., 2008; Meeusen et al., 
2007). Meeusen et al. (1997) showed that 60 min of exercise significantly increased dopamine 
content in the striatum. The same increase in dopamine concentration was seen in the 
midbrain, hypothalamus and hippocampus during exercise (Balthazar et al., 2009, 2010; 
Chaouloff et al., 1987). On the other hand, Bailey et al. (1993) reported reduced cerebral 
dopamine levels after prolonged running, which indicates that low dopamine levels during 
intense exercise may contribute to the reduction in physical capacity through an interference 
with motivation, arousal and the motor drive. It is important to point out that recent studies 
reveal that the variation in the brain dopamine content during exercise exhibits a dynamic 
profile; the levels increase between exercises and return to basal levels at the point of fatigue, 
which is the same time that serotonin content is at its peak (Bailey et al., 2003; Balthazar et al., 
2009; Foley & Fleshner, 2008; Struder & Weicker, 2001a,b). Therefore, it seems that exercise 
continuation is favored by the increase in dopamine brain levels in between exercises, while 
central fatigue is a consequence of the reduced central dopamine concentrations along with 
other factors, such as the increased brain serotonin concentrations. 
Findings that elevations in brain dopamine levels are associated with a delay in fatigue 
come primarily from pharmacological manipulations (Hasegawa et al., 2005; Watson et al., 
2005). The administration of amphetamine, a potent dopamine releaser (Chandler & Blair, 
1980), has been shown to significantly increase running time until exhaustion (Gerald, 1978). 
Acute inhibition of dopamine reuptake with bupropion has also been shown to result in 
exercise performance improvements (Hasegawa et al. 2008; Watson et al., 2005). Similarly, 
central dopamine activation prior to running until fatigue has also been shown to increase 
exercise time (Balthazar et al., 2009). In contrast, the blockade of brain dopaminergic 
receptors markedly reduces exercise tolerance (Balthazar et al., 2010). Interestingly, all of 
these changes in physical capacity were followed by an elevation in body temperature. In 
fact, various studies provide evidence that central dopamine activation plays an important 
role in thermoregulatory mechanisms; this leads to heat loss and body temperature 
reduction by inducing central temperature set-point adjustments and increasing heat 
dissipation through skin vasodilation (Balthazar et al., 2010; Barros et al., 2004; Chaperon et 
al., 2003; Nunes et al., 1991; Varty & Higgins, 1998). Nevertheless, there is evidence that an 
increase in dopamine levels in the preoptic area/anterior hypothalamus is followed by 
hyperthermic responses during exercise (Balthazar et al., 2009, 2010; Hasegawa et al. 2005, 
2008; Watson et al., 2005). Watson et al. (2005) reported that bupropion, despite enabling 
subjects to maintain a greater time-trial power output while in the heat, led to a higher body 
temperature. Hasegawa et al. (2008) showed further evidence that the improved physical 
performance that was a result of bupropion treatment was accompanied by increased brain 
and body temperatures and related to an increase in the concentration of dopamine in the 
preoptic area/anterior hypothalamus. The central activation of dopaminergic transmissions 
also induces a longer time of running until fatigue, despite a higher heat storage and body 
temperature at the fatigue point (Balthazar et al., 2009). In contrast, a central blockade of D1 
or D2 dopaminergic receptors impairs the dissipation of the exercise-induced heat stored 
during running, and results in persistent hyperthermia and markedly reduced exercise 
tolerance (Balthazar et al., 2010). Because the ergogenic response is affected by 
thermoregulation, the preoptic area/anterior hypothalamus seem to be the brain areas in 
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which dopamine exerts its thermoregulatory actions; dopamine modulates heat production 
and dissipation during exercise, thus affecting running performance (Balthazar et al., 2009; 
Hasegawa et al. 2008; Watson et al., 2005). Another possible locus for the effects of central 
dopaminergic stimulation seems to be the dopaminergic reward circuits (Koob & Moal, 
2008). Dopamine, acting on the mesolimbic reward system, could overrule the inhibitory 
signals arising from the central nervous system that normally compromise running 
performance (Balthazar et al., 2009; Hasegawa et al. 2008; Watson et al., 2005). The results of 
the interaction between thermoregulatory and reward adjustments that are induced by 
central dopamine may be an increase in the drive and motivation to continue exercise; this 
increased drive could dampen or override the inhibitory signals that arise from the central 
nervous system that end exercise due to hyperthermia. Therefore, it seems that the 
interference of central dopamine with the development of hyperthermic central fatigue 
depends mainly on the activation of reward circuitries that could overrule the hyperthermic 
inhibitory pathways (Balthazar et al., 2009; Hasegawa et al. 2008; Watson et al., 2005).  
6.3 Noradrenaline 
Little data has been reported on the contribution of noradrenaline in central fatigue.  
Although noradrenaline is associated with arousal, consciousness and reward mechanisms 
in the brain (Roelands & Meeusen, 2010), researchers have shown that elevated brain levels 
of this catecholamine has a negative effect on exercise performance (Piacentini et al., 2002; 
Roelands et al., 2008; Roelands & Meeusen, 2010). The administration of reboxetine, a 
noradrenaline reuptake inhibitor, led to a trend towards a decrease in exercise performance 
in well-trained endurance athletes (Piacentini et al., 2002). This response was later confirmed 
by Roelands et al. (2008), who suggested that an increase in the concentration of 
noradrenaline could be unfavorable for exercise performance because treatment with the 
noradrenaline reuptake inhibitor decreased physical capacity in both normal and high 
ambient temperatures. The inhibitory effect exerted by noradrenaline on physical 
performance, even though it was not accompanied by a significant change in body 
temperature, induced a tendency for hypothermia. This inclination was further corroborated 
by thermal stress scale scores that indicated a cold sense by the subjects after noradrenaline 
reuptake inhibition (Roelands et al., 2008).  
Studies have provided conflicting data about the role of noradrenaline in thermoregulation. 
The literature points out that the divergent thermal effects of noradrenaline depend on the 
type of receptor that is being stimulated. Therefore, it seems that -1 noradrenergic 
receptors mediate a rise in body temperature, while -2 noradrenergic receptors are 
involved in a fall in body temperature (Feleder et al., 2004; Imbery et al., 2008; Quan et al., 
1991, 1992). Noradrenaline administered in the preoptic area induces a hypothermic 
response because of a reduction in the metabolic rate (Quan et al., 1991). This response has 
been shown to be mediated by -2 receptors, as demonstrated by the fact that an -2 agonist 
evoked a dose-dependent decrease in body temperature that was abolished by an -2 
antagonist (Quan et al., 1992). Similar results were found after noradrenaline activation in 
the anterior hypothalamus during rest and exercise (Feleder et al., 2004; Gisolfi & 
Christman, 1980). On the other hand, Myers et al. (1987) suggested that both -1 and -2 
noradrenergic receptors in the hypothalamus are required to evoke hypothermia. Moreover, 
it has been shown that -1 activation of hypothalamic neurons results in a rapid 
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hyperthermia (Feleder et al., 2004) and that -1 agonists infused into the preoptic area evoke 
a quick rise in body temperature (Imbery et al., 2008). 
The involvement of brain noradrenergic transmission in the onset of hyperthermic central 
fatigue is still uncertain. A study from Hasegawa et al. (2008) showed the most convincing 
evidence of the role of noradrenaline on the development of fatigue due to hyperthermia. 
The administration of a dopamine/noradrenaline reuptake inhibitor (bupropion) in the 
heat, prior to exercise until exhaustion, induced an increase in brain and body temperature; 
both were associated with a decreased heat loss response and a better physical capacity 
(Hasegawa et al., 2008). These responses were followed by similar level of increases in the 
concentrations of dopamine and noradrenaline in the preoptic area/anterior hypothalamus. 
Therefore, although bupropion has a higher potency for dopamine than noradrenaline 
(Holm & Spencer, 2000), the results demonstrate that the drug acts in the brain by enhancing 
the concentration of both dopamine and noradrenaline in a nucleus of major importance for 
thermoregulation. The interaction of dopamine and noradrenaline in the preoptic 
area/anterior hypothalamus likely extends the safe limits of hyperthermia. Nonetheless, the 
brain noradrenergic contribution to hyperthermic central fatigue needs to be investigated 
further. Special attention should be given to the interaction between noradrenaline and 
dopamine, in addition to serotonin, on the onset of central fatigue related to hyperthermia. 
7. Brain monoamines and other neurotransmitters on the development of 
central fatigue: Balance between serotonin and dopamine? 
It would be simplistic to assume that central fatigue is a result of the altered metabolism of a 
single neurotransmitter. On the contrary, data indicate that the phenomenon is much more 
complex and includes the interaction between many neurotransmitters that interfere with 
exercise performance, together with thermoregulation, through the modulation of brain 
monoamine concentrations (Bhattacharya & Sen, 1992, Foley & Fleshner, 2008; Leite et al., 
2010; Meeusen et al., 2006, A. G. Rodrigues et al., 2004, 2009). In light of the facts that central 
fatigue is coincident with high body temperature and/or high rates of body heating and 
heat storage and that serotonergic, dopaminergic and noradrenergic transmissions are in 
command of fatigue, the interaction between such systems and with other neurotransmitters 
implicated in thermoregulation seems to affect physical capacity by influencing heat balance 
in important thermoregulatory centers. 
The most commonly described interaction is between serotonin and dopamine (Davis & 
Bailey, 1997; Foley & Fleshner, 2008; Leite et al., 2010; Meeusen et al., 2006). The precursor of 
dopamine, tyrosine, competes with other amino acids, including tryptophan, for entry into 
the brain (Blomstrand, 2006; Fernstrom & Fernstrom, 2006; Foley & Fleshner, 2008; Meeusen 
et al., 2006).  The interaction between serotonin and dopamine may be an important factor 
affecting the central component of fatigue (Foley & Fleshner, 2008; Leite et al., 2010; 
Meeusen et al., 2006). Both serotonin and dopamine transmissions increase in the central 
nervous system due to exercise; however, while serotonin concentration peaks at the fatigue 
point, dopaminergic activity increases in between exercises and returns to resting levels at 
fatigue (Bailey et al., 1993; Balthazar et al., 2009; Foley & Fleshner, 2008; Struder & Weicker, 
2001a,b). On the basis of this data, the "central fatigue hypothesis" postulates that a high 
serotonin/dopamine ratio is associated with poor exercise performance, being the converse 
also true i.e. improvement of exercise performance (Foley & Fleshner, 2008; Leite et al., 2010; 
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Meeusen et al., 2006). In the first case, the increase in the brain activity of serotonin during 
physical activity seems to contribute to fatigue through an inhibition of the central 
dopaminergic system (Foley & Fleshner, 2008; Leite et al., 2010; Meeusen et al., 2006). To 
support such an assumption, it has been demonstrated that the administration of a serotonin 
agonist blocked the exercise-induced increase in brain dopamine concentrations; it has also 
been shown that treatment with a serotonin antagonist prevented a decrease in central 
dopamine levels at exhaustion (Bailey et al., 1993). Therefore, a decline in exercise performance 
seems to depend primarily on a serotonin level increase that could override the ergogenic 
effect of dopamine. Taking into account these data and data that show that both dopamine and 
serotonin mediate thermoregulation, it has been demonstrated that another factor that 
contributes to premature central fatigue is the association of high serotonin/dopamine ratio in 
the hypothalamus with intense hyperthermia (Leite et al., 2010). 
Many studies have focused on analyzing the effects of the relationships between brain 
catecholamines on the development of hyperthermic central fatigue, particularly in regards to 
dopamine and noradrenaline (Hasegawa et al., 2005, 2008; Watson et al., 2005). Both 
neurotransmitters have been implicated in thermoregulation, and both have their activity 
elevated during exercise, likely as a function of the increased sympathetic tonus (Balthazar et 
al., 2009; Davies & Bailey, 1997; Hasegawa et al., 2008). The administration of bupropion has 
been the most commonly used drug to investigate such catecholaminergic interactions 
(Hasegawa et al., 2005, 2008; Watson et al., 2005). The acute administration of bupropion 
during rest has been shown to increase dopamine and noradrenaline levels in the 
hippocampus and in the preoptic area/anterior hypothalamus, and this effect was followed by 
hyperthermic responses (Hasegawa et al., 2005; Piacentini et al., 2003). During exercise, the 
acute ingestion of the drug in humans has been shown to improve time-trial exercise 
performance in a warm environment, despite higher body temperatures (Watson et al., 2005). 
In contrast to acute bupropion administration, the chronic ingestion of the drug does not 
influence time-trial exercise performance under the same environmental conditions, aside 
from inducing lower body temperature values than the temperatures observed during the 
acute bupropion study (Roelands et al., 2009; Watson et al., 2005). The mechanism for these 
observed discrepancies in bupropion administration seems to be the possible adaptation of 
central neurotransmitter homeostases during the treatment (Roelands et al., 2009). Hasegawa 
et al. (2008) showed further evidence that acute bupropion treatment prior to exercise until 
exhaustion in the heat induces increased brain and body temperatures and better physical 
capacity; these effects are both accompanied by similar increases in the concentrations of 
dopamine and noradrenaline in the preoptic area/anterior hypothalamus throughout exercise. 
Therefore, although bupropion has a higher affinity for dopamine than noradrenaline (Holm 
& Spencer, 2000), these results demonstrate that the drug acts in the brain by increasing the 
concentrations of both dopamine and noradrenaline in nuclei of major importance for 
thermoregulation; their interaction probably extends the safe limits of hyperthermia. The 
communication between these catecholamines seems to potentiate motivation, arousal and 
reward, thus enabling subjects to continue to sustain a high power output, despite 
approaching critical levels of body temperatures that could contribute to central fatigue 
development (Balthazar et al., 2009; Hasegawa et al., 2008; Watson et al., 2005). Nevertheless, 
the nature of such interplay between dopamine and noradrenaline is still uncertain.   
Brain serotonergic activity has been demonstrated to be affected by cholinergic 
neurotransmission (Bhattacharya & Sen, 1992). The administration of muscarinic receptor 
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agonists induces a dose-related decrease in the brain concentrations of serotonin. In contrast, 
the muscarinic receptor antagonist, pirenzepine, increases the central levels of this 
monoamine. These results indicate that an inverse relationship exists between the cholinergic 
and serotonergic neurotransmitter systems in the brain (Bhattacharya & Sen, 1992). More 
recent reports show evidence that central cholinergic activation also influences central fatigue 
through interactions with the serotonergic system (A. G. Rodrigues et al., 2004, 2009). Studies 
have shown that the stimulation of heat dissipation mechanisms is related to cholinergic 
activation and produces hypothermia when cholinoceptor agonists are injected centrally (Lin 
et al., 1980, Pires et al., 2007; Prímola-Gomes et al., 2007; A. G. Rodrigues et al., 2004, 2009). 
This effect was seen during exercise after central activation of the cholinergic system with 
physostigmine (an acetylcholinesterase inhibitor). The treatment decreased body heating rate 
and heat storage due to improved heat loss (A. G. Rodrigues et al., 2004, 2009). As a 
consequence, body temperature increases attenuated, which enabled fatigue to be established 
at a lower body temperature without exercise performance improvement. In such a situation, 
the cardiovascular overload was the main inductor of fatigue, prevailing over the hypothermic 
excitatory signals from the central nervous system that could ultimately favor physical work 
performance (Pires et al., 2007). It is important to note that the lower heat storage, as a product 
of central physostigmine treatment, was closely associated with decreased serotonin levels in 
the preoptic area at the moment of fatigue (A. G. Rodrigues et al., 2009). These data indicate 
that cholinergic stimulation abolishes the exercise-induced increase in serotonin content in the 
main thermoregulatory site. Moreover, these data support the idea that central cholinergic 
stimulation promotes decreases in heat storage during exercise by altering the activation of the 
brain serotonergic system.  
Adding to the hypothesis that central fatigue is determined by interactions between 
neuronal signal substances, it has been demonstrated that a central angiotensinergic 
blockade during exercise affects serotonin concentration in the preoptic area and 
hypothalamus, in association with excessive hyperthermia and premature central fatigue 
(Leite et al., 2010). Acting centrally, angiotensin II exerts thermoregulatory effects that are 
characterized by hypothermia (Fregly & Rowland, 1996; K. M. Wilson & Fregly, 
1985).Central treatment with losartan (angiotensin II AT1 receptor antagonist) worsens 
hyperthermia and increases the body heating rate and heat storage rate that are indirectly 
related to the time to fatigue. This hyperthermic response is due to a heat imbalance that is 
characterized by higher heat production and lower peripheral heat loss (Leite et al., 2006, 
2007). These effects of angiotensin II on heat balance during exercise were shown to be 
linked to serotonergic pathways (Leite et al., 2010). These findings provide evidence that the 
inhibition of the central angiotensinergic system during exercise causes an increase in 
serotonin content in the preoptic area and hypothalamus that is directly associated with 
hyperthermia and a higher body heating rate and that is indirectly related to the time to 
fatigue. In addition, although losartan did not alter the concentration of dopamine in the 
analyzed brain areas, it did lead to a high hypothalamic serotonin/dopamine ratio, which 
was directly correlated with the body heating rate and inversely correlated with the time to 
fatigue. Thus, serotonin and dopamine interaction in these regions contributes to 
hyperthermia and premature central fatigue when central angiotensinergic pathways are 
inhibited. Taken together, the data indicate that central angiotensinergic transmission has 
important effects on serotonin levels in the brain during exercise and interacts with 
dopamine-affected central fatigue through a modulation of body temperature control. 
There is also the possibility that serotonin interacts with noradrenaline in the establishment 
of central fatigue, despite results from Piacentini et al. (2002), where the administration of a 
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serotonin/noradrenaline reuptake inhibitor (venlafaxine) had no effect on exercise 
performance. Evidence indicates that the dorsal raphe serotonin neurons receive 
noradrenergic projections from the locus coeruleus (Szabo & Blier, 2001, 2002). Conversely, 
noradrenaline neurons of the locus coeruleus receive dense serotonergic projections mainly 
from the dorsal raphe (Szabo & Blier, 2001, 2002). These pathways suggest the possible 
existence of modulation between the activity of serotonin and noradrenaline in the brain 
nuclei that are responsible for thermoregulation, which could interfere with thermal balance 
and exercise performance.  
A question remains regarding the participation of other neurotransmitters that also 
influence thermal control, such as GABA and glutamate (Ishiwata et al., 2005; Nikolov & 
Yakimova, 2011), which could interact with central monoamines in the development of 
hyperthermic central fatigue. Thus, knowledge of the mechanisms of central fatigue is still 
limited and presupposes a complex interplay of different neurotransmitter systems that 
affect thermoregulation and exercise performance; serotonin, dopamine and noradrenaline 
likely play the most important roles.  
8. Predictors of fatigue: Static and dynamic perspectives 
The combination of exercise with excessive hyperthermia appears to diminish the central 
nervous system drive to the working muscles, protecting the brain from thermal damage in 
detriment of exercise performance (Kay & Marino, 2000; Nielsen & Nybo, 2003; Noakes, 1998). 
The thermoregulatory-sensed variables that initiate these central inhibitory signals of exercise 
performance in order to avoid heat stroke are still the subject of debate. Even though it has 
been stated that central fatigue coincides with the attainment of fixed high body and brain 
temperatures (Fuller et al., 1998; Gonzalez-Alonso et al., 1999; Nielsen et al., 1993; Walters et 
al., 2000), there is evidence that dynamic mechanisms are consistent regulators of feelings of 
fatigue. In support of this hypothesis, the rates of heat storage and body heating that are 
associated with changes in neurotransmitter content in thermoregulatory centers emerge as 
important factors in determining fatigue (Cheuvront et al., 2010; Hasegawa et al., 2008; 
Lacerda et al., 2005, 2006; Leite et al., 2006, 2010, L. O. Rodrigues et al., 2003; A. G. Rodrigues et 
al., 2004, 2009; Soares et al., 2004, 2007; Wanner et al., 2007). 
Reaching critically high and predetermined body and brain temperatures, very close to the 
level of heat stroke, has been proposed as an ultimate warning sign that causes a reduction 
in the mental drive for exercise performance (Fuller et al., 1998; Gonzalez-Alonso et al., 1999; 
Nielsen et al., 1993; Walters et al., 2000). In this light, fatigue would be anticipated by such a 
static thermal indicator, which would establish a hyperthermic threshold to prevent 
homeostasis failure. There are a number of reports that have linked the attainment of a 
decisive high body temperature to the settlement of fatigue in humans and in animals. This 
was the conclusion of Nielsen et al. (1993), who reported that endurance-trained individuals 
always stopped exercising until exhaustion (~60% of VO2 max) when esophageal 
temperatures reached 39.5C. In addition, these subjects exhibited a prolonged endurance 
time after 9-12 consecutive days of exercising at an ambient temperature of 40°C, which was 
associated with a decreased body temperature rise rate; these changes suggest that the body 
heating rate could interfere with the physical capacity. To hold Nielsen’s hypothesis, results 
from Fuller et al. (1998) indicate that exercise (~60% of VO2 max) trials that differed in 
ambient temperature (33.0 and 38.0C) and initial body temperature (23 and 38C) promoted 
fatigue at the same abdominal (~39.9C) and brain temperatures (~40.2C). It is important to 
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point out that the exercises were executed under a higher thermal load that induced fatigue 
earlier, which leaves open the possibility that the rates of body heating and heat storage 
might have been higher in this circumstance to enable fatigue to be reached at equal 
abdominal and brain temperatures. This possibility was seen in the case of trained subjects 
cycling in the heat (60% VO2, 40°C), whose time to fatigue was directly related to the body 
temperature increase rate, which was controlled at 0.10 or 0.05°C/min-1, and inversely 
related to the initial level of esophageal temperature (35.9  0.2, 37.4  0.1, or 38.2  0.1) 
(Gonzalez-Alonso et al., 1999). In both experimental conditions, all subjects reached 
exhaustion at similar esophageal (40.1–40.2°C) and muscle temperatures (40.7–40.9°C) 
(Gonzalez-Alonso et al., 1999). However, the manipulation of the body temperature increase 
rate was restricted to a very narrow range and was possibly not large enough to induce 
noticeable changes in body temperature. Moreover, individual body temperatures respond 
differently to heat stimuli and depend on many factors, such as dehydration, nutrition, 
fitness and motivation, as well as exercise intensity and thermal environmental stress (Kay 
& Marino, 2000; L. O. Rodrigues et al., 2003). Therefore, in absolute terms, the thermal load 
imposed would be expected to vary between subjects. Also contributing to the concept that 
a critical body temperature limits exercise, Walters et al. (2000) demonstrated that running 
(~60% of VO2max) at an ambient temperature of 35°C establishes both hypothalamic and 
rectal temperatures at exhaustion of 42.1°C and 42.4°C, respectively, regardless of a 
manipulation in the initial hypothalamic temperature (41.5°C, 42.5°C or 43.5°C). The 
hypothalamic and rectal temperatures before exercise correlate negatively with the run-
time until exhaustion, which means that the run-time to exhaustion was significantly 
reduced after preheating. Interestingly, the rectal temperatures at the fatigue point that 
were observed by the authors were considerably higher than previously seen with 
exercise at approximately the same intensity (Fuller et al., 1998). Furthermore, the body 
temperature values at fatigue from the studies mentioned above (Fuller et al., 1998; 
Walters et al., 2001) also differed from the data from Soares et al. (2004), who 
demonstrated that increased central serotonin availability with tryptophan treatment 
before exercise (~66% of VO2max) resulted in the same intraperitoneal temperature at 
fatigue as in the control group (38.32°C tryptophan vs. 38.03°C saline). It is important to 
point out that the tryptophan administration elevated the body heating rate and the heat 
storage rate, and both were negatively correlated with the time to fatigue. Therefore, 
central serotonergic-activation-induced higher body temperature variations are associated 
with increased body heating and heat storage rates, which anticipated fatigue (Soares et 
al., 2004). This detail allows for the possibility that reaching a critically high body 
temperature by itself may not be the main factor in predicting fatigue. In fact, this result is 
in agreement with the concept that dynamic variables strongly contribute to the reduction 
of physical performance (Cheuvront et al., 2010; Hasegawa et al., 2008; Lacerda et al., 
2005, 2006; Leite et al., 2006, 2010, L. O. Rodrigues et al., 2003; A. G. Rodrigues et al., 2004, 
2009; Soares et al., 2004, 2007; Wanner et al., 2007). 
There are many findings that differ from the hypothesis that fatigue is predicted by a 
defined high body temperature (Cheuvront et al., 2010; Hasegawa et al., 2008; Lacerda et al., 
2005, 2006; Leite et al., 2006, 2010, L. O. Rodrigues et al., 2003; A. G. Rodrigues et al., 2004, 
2009; Soares et al., 2004, 2007; Wanner et al., 2007). These findings show that the rates of 
body heating and heat storage play an important role in signaling fatigue development to 
the brain. Both parameters are characterized by the variation of body temperature as a 
function of time; the heat storage rate is further corrected for body weight (Lacerda et al., 
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2005, 2006; Leite et al., 2006, 2010, L. O. Rodrigues et al., 2003; A. G. Rodrigues et al., 2004, 
2009, Soares et al., 2004, 2007; Wanner et al., 2007). Recently, it has been proposed that skin 
temperature also provides important sensory input to the central nervous system during 
exercise in the heat and has a negative effect on performance that worsens as the cutaneous 
temperature progressively increases (Cheuvront et al., 2010). 
Considering this dynamic hypothesis, L. O. Rodrigues et al. (2003) demonstrated that 
exhaustion was inversely correlated with the heat storage rate during running at a speeds of 
21 or 24 m/min, without an incline in the treadmill, at three different ambient temperatures 
(18.0, 23.1 or 29.4°C). The exercise under the higher intensity and thermal load resulted in 
precipitation of fatigue. More importantly, the intraperitoneal body temperature at the 
fatigue point was different between the groups and higher after running in the heat. This 
profile was also seen by Hasegawa et al. (2008), whose data demonstrated that both 
intraperitoneal and brain temperatures at the point of exhaustion were significantly lower 
after exercise in a cool condition (18.0°C) compared to a warm environment (30 °C). 
Therefore, in these two examples, the body temperature at the point of exhaustion in the 
cool condition did not reach the critical level. Brain manipulations of 
neurotransmitters/neuromodulators during exercise also give strong evidence of the 
involvement of dynamic variables on the reduction in exercise time. Central nitric oxide 
blockade with L-NAME (N-nitro-l-arginine methyl ester, a nitric oxide synthase inhibitor) 
results in higher intraperitoneal body temperatures at fatigue and lower exercise 
performances (Lacerda et al., 2005). Due to the increased heat production associated with 
decreased heat loss, this treatment results in a higher body heating rate that rapidly 
produces hyperthermia (Lacerda et at., 2005, 2006). It is important to point out that the 
reduced exercise performance observed after a blockade of nitric oxide pathways is closely 
associated with the higher body heating rate (Lacerda et al., 2005). This relationship is 
absent after a stimulation of the central cholinergic transmissions during exercise (~66% of 
VO2max). Although this treatment attenuated colonic temperature increases, the time to 
fatigue was not affected, which was the same as that of controls (A. G. Rodrigues et al., 
2004). This evidence emphasizes that even though both groups reached fatigue at the same 
moment, the body temperature at fatigue was different between groups; that is, body 
temperatures were lower after central cholinergic stimulation, which is attributable to the 
activation of heat loss mechanisms (A. G. Rodrigues et al., 2004, 2009). Additionally, this 
treatment promoted a decrease in the body heating rate (A. G. Rodrigues et al., 2004). On the 
other hand, a direct relationship between the heat storage rate and the time to fatigue was 
present when cholinergic transmissions where blocked by a central administration of 
methylatropine (a muscarinic receptor antagonist) (Wanner et al., 2007). A central 
cholinergic blockade during running (~80% of VO2max) increases the heat storage rate, 
leading to greater exercise-induced hyperthermia and a higher intraperitoneal temperature 
at fatigue, which is followed by exercise performance impairments. Therefore, the increased 
heat storage rate, as a consequence of a higher metabolic cost and decreased heat 
dissipation, contributes significantly to the interruption of exercise (Wanner et al., 2007, 
2011). Adding to the hypothesis that fatigue is determined by active variables, Leite et al. 
(2006) verified that a close correlation between the elevated body heating rate and the 
reduced time to fatigue (~66% of VO2max) is seen after central angiotensinergic blockade 
with losartan. This treatment increases intraperitoneal temperatures at the fatigue point 
because of an enhanced heat production that is not compensated by a proportional heat loss 
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(Leite et al., 2006, 2007). Thus, an infusion of losartan induces a significant increase in the body 
heating rate, and also the heat storage rate, that rapidly produces aggravation of hyperthermia 
and reduces exercise performance (Leite et al., 2010). In view of the fact that dissimilar values 
of body temperatures at the fatigue point were seen between groups assessed with distinct 
approaches, the authors postulated that as the elevated rates of body heating and heat storage 
progressively exacerbate the exercise-induced hyperthermia, the central nervous system 
becomes sensitive to such a dynamic event and induces fatigue as a safety mechanism to 
prevent a dangerously high body temperature that could jeopardize physical integrity.  
Recent findings have also associated elevated rates of body heating and heat storage with high 
levels of serotonin in centers responsible for thermoregulation (Leite et al., 2010; A. G. 
Rodrigues et al., 2009; Soares et al., 2007). In the case of central angiotensinergic blockade, the 
augmented body heating rate and reduced exercise performance were directly associated with 
high levels of serotonin at fatigue in thermoregulatory centers like the preoptic area and 
hypothalamus (Leite et al., 2010). An elevation of serotonin content in the preoptic area is also 
related to increased body temperature variations and a reduced time to fatigue shown by 
central serotonin activation (Soares et al., 2007). In contrast, lower heat storage, which 
attenuates the exercise-induced hyperthermia as a result of stimulation of the central 
cholinergic system, is closely associated with decreased serotonin levels in the preoptic area at 
the moment of fatigue (A. G. Rodrigues et al., 2009). Central dopamine metabolism is also 
enhanced during exercise (Balthazar et al., 2009; Foley & Fleshner, 2008; Hasegawa et al., 2005), 
and its interaction with serotonin has been linked with high rates of body heating and 
precipitation of fatigue (Foley & Fleshner, 2008; Meeusen et al., 2007). A combination of effects 
is induced by central angiotensinergic blockade, which leads to a higher serotonin/dopamine 
ratio within the hypothalamus at fatigue that correlates directly with the body heating rate and 
indirectly with the exercise time to fatigue (Leite et al., 2010). This observation asserts that the 
high concentrations of serotonin achieved during exercise, in addition to their interactions 
with dopamine in nuclei responsible for thermoregulation, contribute to the increases in body 
heating and heat storage rates, thereby adding to exercise-induced hyperthermia and 
decreasing running performance. Changes in neurotransmitter content in thermoregulatory 
centers, which are associated with afferent feedback arising from variations in the body 
heating and heat storage rates during exercise, provide new insights into possible mechanisms 
by which individuals may terminate exercise.  
9. Conclusions  
The mechanisms underlying hyperthermic central fatigue include decreased efferent 
signaling from the central nervous system that protects the brain from thermal damage. 
There is strong evidence that these mechanisms depend greatly on monoamine traffic, 
mainly the serotonin/dopamine ratio, in thermoregulatory centers. Hyperthermic central 
fatigue during exercise should be seen essentially as a defense mechanism. Reaching a 
critically high body temperature, by itself, may not be the main factor in predicting fatigue. 
In fact, this is in agreement with the concept that dynamic variables determine physical 
performance more than static ones.  
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